SI1651260T2 - Lawsonia intracellularis evropskega izvora in vakcine, diagnostična sredstva in postopki za njihovo uporabo - Google Patents

Lawsonia intracellularis evropskega izvora in vakcine, diagnostična sredstva in postopki za njihovo uporabo

Info

Publication number
SI1651260T2
SI1651260T2 SI200431296T SI200431296T SI1651260T2 SI 1651260 T2 SI1651260 T2 SI 1651260T2 SI 200431296 T SI200431296 T SI 200431296T SI 200431296 T SI200431296 T SI 200431296T SI 1651260 T2 SI1651260 T2 SI 1651260T2
Authority
SI
Slovenia
Prior art keywords
intracellularis
vaccines
methods
diagnostic agents
lawsonia intracellularis
Prior art date
Application number
SI200431296T
Other languages
English (en)
Other versions
SI1651260T1 (sl
Inventor
Michael B Roof
Jeremy J. Kroll
Jeffrey P. Knittel
Original Assignee
Boehringer Ingelheim Vetmedica, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34115340&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1651260(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica, Inc. filed Critical Boehringer Ingelheim Vetmedica, Inc.
Publication of SI1651260T1 publication Critical patent/SI1651260T1/sl
Publication of SI1651260T2 publication Critical patent/SI1651260T2/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200431296T 2003-07-25 2004-07-15 Lawsonia intracellularis evropskega izvora in vakcine, diagnostična sredstva in postopki za njihovo uporabo SI1651260T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49000103P 2003-07-25 2003-07-25
EP04778282.6A EP1651260B2 (en) 2003-07-25 2004-07-15 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
PCT/US2004/022704 WO2005011731A1 (en) 2003-07-25 2004-07-15 Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof

Publications (2)

Publication Number Publication Date
SI1651260T1 SI1651260T1 (sl) 2010-01-29
SI1651260T2 true SI1651260T2 (sl) 2018-09-28

Family

ID=34115340

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431296T SI1651260T2 (sl) 2003-07-25 2004-07-15 Lawsonia intracellularis evropskega izvora in vakcine, diagnostična sredstva in postopki za njihovo uporabo

Country Status (23)

Country Link
US (2) US7312065B2 (sl)
EP (1) EP1651260B2 (sl)
JP (1) JP2006528882A (sl)
KR (1) KR101131845B1 (sl)
CN (2) CN101423811A (sl)
AT (1) ATE442163T2 (sl)
AU (1) AU2004260657B2 (sl)
BR (1) BRPI0412911B1 (sl)
CA (1) CA2533559C (sl)
CY (1) CY1109652T1 (sl)
DE (1) DE602004023094D1 (sl)
DK (1) DK1651260T4 (sl)
ES (1) ES2333334T5 (sl)
MX (1) MXPA06000994A (sl)
MY (1) MY140208A (sl)
PL (1) PL1651260T5 (sl)
PT (1) PT1651260E (sl)
RU (1) RU2420570C2 (sl)
SG (1) SG144909A1 (sl)
SI (1) SI1651260T2 (sl)
UA (1) UA87665C2 (sl)
WO (1) WO2005011731A1 (sl)
ZA (1) ZA200510081B (sl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
AU2012207016B2 (en) * 2005-03-14 2015-01-15 Boehringer Ingelheim Animal Health USA Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP2275130A3 (en) * 2005-12-29 2011-03-23 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 immunogenic composition
EP2275132B1 (en) 2005-12-29 2021-03-03 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing them
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (en) * 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
MX2009006066A (es) 2006-12-15 2009-06-17 Boehringer Ingelheim Vetmed Tratamiento de cerdos con el antigeno pcv.
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
US8398970B2 (en) * 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
WO2009088950A2 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
BRPI0907438A2 (pt) 2008-01-23 2015-08-04 Boehringer Ingelheim Vetmed Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
EP2254595A4 (en) * 2008-02-15 2012-12-05 Boehringer Ingelheim Vetmed METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
EP2318041B1 (en) 2008-07-22 2015-02-25 Intervet International BV Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
WO2011054951A1 (en) 2009-11-09 2011-05-12 Intervet International B.V. Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
SI2691530T1 (sl) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glikoproteini in rekombinantni vektorji
WO2015048115A1 (en) 2013-09-25 2015-04-02 Zoetis Llc Pcv2b divergent vaccine composition and methods of use
AU2014329524B2 (en) 2013-10-02 2019-01-17 Boehringer Ingelheim Animal Health USA Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
RU2672251C1 (ru) * 2013-12-03 2018-11-13 Интервет Интернэшнл Б.В. Вакцина против lawsonia intracellularis и свиного цирковируса 2-го типа
CN103823063B (zh) * 2014-02-25 2015-09-30 上海理工大学 检测猪霍乱沙门氏菌的方法及其单抗
BR112017016437A2 (pt) 2015-02-04 2018-04-10 Intervet Int Bv ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis?
KR101893827B1 (ko) * 2016-01-04 2018-08-31 전북대학교 산학협력단 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
CA3088651A1 (en) 2018-02-28 2019-09-06 Boehringer Ingelheim Vetmedica Gmbh Method for reducing skatole and/or indole in animals
KR102249189B1 (ko) * 2020-01-09 2021-05-07 전북대학교 산학협력단 항원성이 증진된 항원을 발현하는 약독화된 살모넬라 변이주를 유효성분으로 포함하는 돼지 증식성 회장염 및 살모넬라증 동시 예방 또는 치료용 백신 조성물
US20230241198A1 (en) * 2020-07-24 2023-08-03 Boehringer Ingelheim Animal Health USA Inc. Combination porcine vaccine
CN111961627A (zh) * 2020-08-27 2020-11-20 南京农业大学 一种胞内劳森菌的分离与培养方法
US20230141226A1 (en) 2021-11-01 2023-05-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) † 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

Also Published As

Publication number Publication date
RU2420570C2 (ru) 2011-06-10
UA87665C2 (ru) 2009-08-10
CA2533559A1 (en) 2005-02-10
ES2333334T3 (es) 2010-02-19
PT1651260E (pt) 2009-09-24
EP1651260B1 (en) 2009-09-09
US7758870B2 (en) 2010-07-20
ATE442163T2 (de) 2009-09-15
BRPI0412911A (pt) 2006-09-26
US20080112980A1 (en) 2008-05-15
SG144909A1 (en) 2008-08-28
ZA200510081B (en) 2006-08-30
RU2006105715A (ru) 2007-09-10
CN1829529B (zh) 2011-05-04
PL1651260T5 (pl) 2018-11-30
CN101423811A (zh) 2009-05-06
EP1651260B2 (en) 2018-06-27
JP2006528882A (ja) 2006-12-28
WO2005011731A1 (en) 2005-02-10
DK1651260T3 (da) 2010-01-11
SI1651260T1 (sl) 2010-01-29
PL1651260T3 (pl) 2010-02-26
ES2333334T5 (es) 2018-08-06
US20050031647A1 (en) 2005-02-10
EP1651260A1 (en) 2006-05-03
DE602004023094D1 (de) 2009-10-22
DK1651260T4 (en) 2018-10-08
CA2533559C (en) 2013-07-02
BRPI0412911B1 (pt) 2020-01-21
MY140208A (en) 2009-11-30
US7312065B2 (en) 2007-12-25
CY1109652T1 (el) 2014-08-13
AU2004260657B2 (en) 2012-06-07
KR20060054352A (ko) 2006-05-22
MXPA06000994A (es) 2006-05-15
KR101131845B1 (ko) 2012-03-30
AU2004260657A1 (en) 2005-02-10
CN1829529A (zh) 2006-09-06

Similar Documents

Publication Publication Date Title
SI1651260T2 (sl) Lawsonia intracellularis evropskega izvora in vakcine, diagnostična sredstva in postopki za njihovo uporabo
MXPA01011047A (es) Secuencias genomicas de neisseria y metodos para su uso.
WO2007064742A3 (en) Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
FR13C0040I2 (fr) Vaccins polypeptidiques offrant une large protection contre des lignees de meningocoques hypervirulentes
WO2008112344A3 (en) Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
HUP0302965A2 (hu) Vakcina
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
WO2002034773A3 (en) Streptococcal genes
TW200510524A (en) Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
WO2000062803A3 (en) ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
UA67249A (en) Strain paramixovirus-3 bovis "m-87" for the preparation of vaccine and diagnostic antigen
UA6097U (en) Process for preparation of multivac vaccine for prevention and treatment of widespread infectious diseases of animals caused by infectious associated etiologic agent
MY188912A (en) Attenuated bacteria for use in a vaccine
MY168662A (en) Attenuated bacteria for use in a vaccine